Skip to main content
Figure 3 | Filaria Journal

Figure 3

From: Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence

Figure 3

Antigen and antifilarial antibody prevalence for A, persons who received treatment (n = 126) and B, persons who did not receive treatment (n = 34) in 2000 (solid bars) and 2001 (cross-hatched bars). The error bar represents the upper 95% confidence interval. Among persons who received treatment antigen and antifilarial IgG1 prevalences decreased significantly. Among person who did not receive treatment, antifilarial IgG1 prevalence increased significantly.

Back to article page

Filaria Journal

ISSN: 1475-2883